Related Experiment Video
Updated: May 27, 2025

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
Published on: June 14, 2017
Longitudinal analysis of lentiviral and retroviral chimeric antigen receptors' integration sites reveals distinct
Vincent Guiraud1, Jerome Alexandre Denis2, Ghizlane Benhafoun1
1Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Sante Publique (IPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
Abstract:
T-cell malignancies following chimeric antigen receptor (CAR) therapies are partly related to insertional mutagenesis, but the longitudinal evolution of CAR-integration sites (IS) remains understudied. We performed an IS analysis in blood from three tisagenlecleucel (lentiviral), one axicabtagene-ciloleucel and one brexucabtagene-autoleucel (gammaretrovirals) patient at peak expansion and 1-year follow-up. All were complete responders. Peak expansion IS patterns were vector dependent: lentiviral CAR integrated mostly in introns and gammaretrovirals in intergenic regions, closer to transcription start sites. At 1-year post-infusion, lentiviral CAR showed no major clonal proliferation. Gammaretroviral CARs had divergent outcomes: no detectable CAR (axicabtagene-ciloleucel) or low-level oligoclonal persistence (brexucabtagene-autoleucel). Whether this latter evolution is at risk of further CAR malignancies needs further investigations.
Insights
Chimeric antigen receptor (CAR) T-cell therapy integration sites differ by vector type. Lentiviral CARs showed stable integration, while gammaretroviral CARs had variable persistence, necessitating further study for malignancy risk.
Area of Science:
- Oncology
- Immunotherapy
- Molecular Biology
Background:
- Chimeric antigen receptor (CAR) T-cell therapies offer potent cancer treatments.
- CAR T-cell malignancies are linked to insertional mutagenesis, but longitudinal CAR integration site (IS) evolution is not well understood.
Purpose of the Study:
- To investigate the longitudinal evolution of CAR integration sites (IS) following different CAR T-cell therapies.
- To compare IS patterns and clonal persistence between lentiviral and gammaretroviral vectors.
Main Methods:
- Integration site analysis in patient blood samples at peak CAR T-cell expansion and 1-year follow-up.
- Analysis included patients treated with tisagenlecleucel (lentiviral), axicabtagene-ciloleucel, and brexucabtagene-autoleucel (gammaretrovirals).
Main Results:
- Peak expansion IS patterns were vector-dependent: lentiviral CARs integrated in introns, while gammaretrovirals integrated in intergenic regions near transcription start sites.
- One year post-infusion, lentiviral CAR showed no significant clonal proliferation.
- Gammaretroviral CARs exhibited divergent outcomes: undetectable CAR in one patient and low-level oligoclonal persistence in another.
Conclusions:
- CAR T-cell integration site patterns are influenced by vector type.
- Longitudinal CAR T-cell persistence varies significantly between lentiviral and gammaretroviral vectors.
- The long-term implications and potential malignancy risk associated with persistent gammaretroviral CARs require further investigation.
Related Concept Videos
Non-LTR Retrotransposons
Viral Recombination
Retroviruses

